ArticleCureus2024

Mifepristone's Efficacy for Symptomatic Relief and Size Reduction in Uterine Fibroids: A 2023 Prospective Observational Study at Rabia Balkhi Hospital, Afghanistan.

Bibi Sarah Yousofzai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.